In the competitive life and health insurance sector, AFL and MET stand out as major players offering stability amid market volatility. This stock comparison analyzes their recent performance, financial metrics, and market positioning, helping traders and long-term investors assess relative strengths. With both firms navigating interest rate shifts and economic uncertainties, understanding their growth drivers, momentum, and risks provides valuable insights for portfolio allocation in the financial services space.
Aflac Incorporated (AFL) specializes in supplemental health and life insurance products, with significant exposure in Japan and the U.S. market. Trading around $115 per share in recent market activity, the stock has maintained stability within a 52-week range of about $97 to $119. Its market cap exceeds $59 billion, supported by trailing twelve-month (TTM) earnings per share (EPS) of $6.82 and quarterly revenue near $4.3 billion. Recent weeks have seen modest gains of around 8%, influenced by anticipation for upcoming first-quarter results and ongoing dividend growth—marking a 43-year streak. Sentiment reflects community health initiatives and Japan business resilience, though some analysts cite premium pressures and maintain cautious ratings.
MetLife, Inc. (MET) provides a broad range of life insurance, annuities, and employee benefits globally, with a focus on diversified operations. The stock recently closed near $78, up over 2% in a session, within a 52-week range of $67 to $84. Market cap stands at approximately $51 billion, with TTM EPS of $4.71 and substantial quarterly revenue topping $24 billion. Recent performance has been robust, with nearly 14% gains over the past month, driven by positive previews of variable investment income ($475-525 million pre-tax) and analyst upgrades. Corporate initiatives in climate innovation and philanthropy have also supported favorable market sentiment ahead of earnings.
Tickeron’s Trending AI Robots page features a curated selection of over 25 top-performing AI trading bots from a library of 351, tailored to current market conditions across stocks, ETFs, and more. These bots employ diverse strategies like trend trading and AI/ML pattern recognition on timeframes from 5 minutes to daily, delivering impressive stats such as annualized returns ranging from 65% to over 167%, win rates of 56-75%, and profit factors up to 3.61. Examples include semiconductor-focused agents on tickers like NVDA and SOXL with 70-100% returns, and multi-ticker industrials bots emphasizing risk-managed entries. Traders can copy these virtual agents for automated execution, with no minimum balances required for some. Explore the page to identify bots aligning with your risk tolerance and timeframe.
AFL emphasizes niche supplemental insurance, deriving strength from Japan sales persistence, while MET pursues broader life and group benefits with greater international diversification. Growth drivers differ: AFL benefits from dividend reliability, but MET leverages investment income variability for upside. Recent momentum favors MET with sharper gains, contrasting AFL's steadier trajectory. Risk factors include interest rate sensitivity affecting reserves for both, though MET's scale offers resilience. Sector exposure aligns in financials, yet MET garners stronger buy ratings and sentiment from momentum plays.
Tickeron’s AI currently leans toward MET based on superior trend consistency in recent weeks, positive investment income catalysts, and relative upside in analyst targets. AFL remains a solid stability pick, but MET's momentum and valuation positioning suggest higher probability of near-term outperformance in the current environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AFL’s FA Score shows that 1 FA rating(s) are green whileMET’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AFL’s TA Score shows that 3 TA indicator(s) are bullish while MET’s TA Score has 4 bullish TA indicator(s).
AFL (@Life/Health Insurance) experienced а -0.35% price change this week, while MET (@Life/Health Insurance) price change was -0.11% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.14%. For the same industry, the average monthly price growth was +2.21%, and the average quarterly price growth was +2.92%.
AFL is expected to report earnings on Aug 06, 2026.
MET is expected to report earnings on Aug 05, 2026.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| AFL | MET | AFL / MET | |
| Capitalization | 59.3B | 56.3B | 105% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 6.807 | 12.569 | 54% |
| P/E Ratio | 13.32 | 16.94 | 79% |
| Revenue | 18.3B | 76B | 24% |
| Total Cash | 71.5B | 121B | 59% |
| Total Debt | 7.91B | 21.1B | 37% |
AFL | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 74 | 73 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 32 Undervalued | |
PROFIT vs RISK RATING 1..100 | 4 | 38 | |
SMR RATING 1..100 | 71 | 96 | |
PRICE GROWTH RATING 1..100 | 51 | 27 | |
P/E GROWTH RATING 1..100 | 70 | 29 | |
SEASONALITY SCORE 1..100 | 50 | 36 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (32) in the Life Or Health Insurance industry is somewhat better than the same rating for AFL (66). This means that MET’s stock grew somewhat faster than AFL’s over the last 12 months.
AFL's Profit vs Risk Rating (4) in the Life Or Health Insurance industry is somewhat better than the same rating for MET (38). This means that AFL’s stock grew somewhat faster than MET’s over the last 12 months.
AFL's SMR Rating (71) in the Life Or Health Insurance industry is in the same range as MET (96). This means that AFL’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (27) in the Life Or Health Insurance industry is in the same range as AFL (51). This means that MET’s stock grew similarly to AFL’s over the last 12 months.
MET's P/E Growth Rating (29) in the Life Or Health Insurance industry is somewhat better than the same rating for AFL (70). This means that MET’s stock grew somewhat faster than AFL’s over the last 12 months.
| AFL | MET | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 32% | 2 days ago 64% |
| Stochastic ODDS (%) | 2 days ago 47% | 2 days ago 59% |
| Momentum ODDS (%) | 2 days ago 44% | 2 days ago 53% |
| MACD ODDS (%) | 2 days ago 36% | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 39% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 33% | 2 days ago 50% |
| Advances ODDS (%) | 14 days ago 56% | 12 days ago 63% |
| Declines ODDS (%) | 6 days ago 38% | 6 days ago 53% |
| BollingerBands ODDS (%) | 6 days ago 57% | 2 days ago 65% |
| Aroon ODDS (%) | 2 days ago 61% | 2 days ago 48% |
A.I.dvisor indicates that over the last year, AFL has been loosely correlated with CNO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AFL jumps, then CNO could also see price increases.
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.